罗沙司他胶囊 | China Drugs ListRoxadustat capsules | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 药品类型
- 化学药Chemical medicine
- 治疗领域
- 肾脏疾病Kidney diseases
- 公开来源记录的适应症
- 用于治疗慢性肾脏病（CKD）引起的贫血，包括透析及非透析患者。本段已核对成都国为同通用名仿制药说明书；原研品牌说明书全文仍待取得。Treatment of anemia caused by chronic kidney disease (CKD), in both dialysis-dependent and non-dialysis-dependent patients. This summary was checked against prescribing information for a generic product from Chengdu Guowei with the same active ingredient; the complete originator-brand prescribing information is still unavailable.
- 适应症来源与口径
- 来源日期： 2025-07-31. 生产商面向中国大陆的药品说明书。 成都国为生产的仿制药说明书，并非原研品牌说明书。Source date(s): 2025-07-31. Manufacturer prescribing information for Mainland China. Generic label from Chengdu Guowei; not the originator brand.
- 说明书信息局限
- 已取得同成分仿制药的完整中文说明书。尚未取得原研品牌说明书。Complete Chinese label obtained for a generic with the same ingredient. The originator brand label remains unavailable.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 日本: 已取得当地获批／上市公告及官方价格来源。每条价格记录注明适应症与日期；未全面核查其他市场。Japan: local approval / launch announcements and official price sources obtained. Indications and dates are specified in each price record; other markets not exhaustively reviewed.
- 医保分类
- 已纳入国家医保（乙类）Included in national insurance (Category B)
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保限制
- 限慢性肾脏病(CKD)引起的贫血。Limited to anemia caused by CKD.
- 医保核查说明
- 按成分／剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.